Chintan A. Parekh, MBBS, MD

Associate Professor of Clinical Pediatrics

Image of Chintan A. Parekh, MBBS, MD
Is this your profile? Click to edit


  • Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia population Br J Haematol. 2023 07; 202(1):e3-e6. . View in PubMed
  • Preclinical Evaluation of a Novel Dual Targeting PI3Kd/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia Front Oncol. 2021; 11:766888. . View in PubMed
  • Integrin a6 mediates the drug resistance of acute lymphoblastic B-cell leukemia Blood. 2020 07 09; 136(2):210-223. . View in PubMed
  • The PI3Kd Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL Cancers (Basel). 2017 Sep 10; 9(9). . View in PubMed
  • A 5-year Old Immigrant Child With a Mediastinal Mass Pediatr Infect Dis J. 2017 11; 36(11):1109. . View in PubMed
  • Convergent BCL6 and lncRNA promoters demarcate the major breakpoint region for BCL6 translocations Blood. 2015 Oct 01; 126(14):1730-1. . View in PubMed
  • Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen J Neurooncol. 2011 Jul; 103(3):673-80. . View in PubMed